T.06.1 CROHN'S DISEASE PATIENTS WITH USTEKINUMAB-INDUCED REMISSION ARE CHARACTERIZED BY HIGH BASELINE IL23 RECEPTOR EXPRESSION IN THE LAMINA PROPRIA TH1 CELLS. (March 2023) - Onali, S.; Di Petrillo, A.; Favale, A.; Carpineti, C.; Cadoni, M.; Loddo, E.; Fantini, M.C.